AKUMS.NS
Akums Drugs & Pharmaceuticals Ltd.$604.70
+0.44%Jun 19, 2026
Market cap
$95.69B
52w range
—
P / E
—
EPS
—
Volume
—
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Akums Drugs & Pharmaceuticals Ltd.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →AKUMS.NS
604.70+12.81%H 634.95L 410.10MA50 544.96MA200 477.53Avg vol 253K
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+1.71%
- Consumer Cyclical+1.70%
- Utilities+1.47%
- Financial Services+1.16%
- Industrials+1.15%
- Basic Materials+0.81%
- Consumer Defensive+0.75%
- Communication Services+0.37%
- Energy-0.55%
- Real Estate-0.71%
- Healthcare-0.91%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic+1.91%
- Biotechnology+7.72%
- Financial - Mortgages+6.37%
- Furnishings, Fixtures & Appliances+4.30%
- Business Equipment & Supplies+4.20%
- Electronic Gaming & Multimedia+3.87%
- Real Estate - Development+3.74%
- Paper, Lumber & Forest Products+3.43%
- Hardware, Equipment & Parts+3.41%
- Construction+3.36%
- Home Improvement+3.36%
- Banks+3.27%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for AKUMS.NS.
Peers
No peer list available for AKUMS.NS.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|